Slump sale of Capsule business extended to Dec 31, 2026

Core Business DivestedStrategic Transactions View source PDF

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.0%1-day move

₹10.40

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+0.0-1.9————————

Up moveDown movePending

AI summary

Nectar Lifesciences is transferring its Empty Hard Gelatin Capsule business to Capnest Health Care Private Limited on a slump sale basis. Both parties have mutually agreed to extend the expected completion date to on or before December 31, 2026. Earlier disclosures were made on December 20, 2025 and April 28, 2026. Other terms and disclosures remain unchanged.

Likely market impact

Deal timeline pushed beyond original schedule, but terms unchanged. Watch for completion by year-end and clarity on sale proceeds.